SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • February 28th, 2024 • Viatris Inc • Pharmaceutical preparations • Pennsylvania
This Separation Agreement and Release (“Agreement”) is made by and between Anthony Mauro (“Executive”) and Viatris Inc. (together with its affiliates, the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
OMNIBUS AMENDMENT NO. 2Viatris Inc • February 28th, 2024 • Pharmaceutical preparations
This OMNIBUS AMENDMENT NO. 2, effective as of December 19, 2023 (this “Amendment”), is by and among Viatris Inc., a Delaware corporation (“Viatris”), Biocon Biologics UK Limited, a U.K. private limited company (“Biocon UK”), Biosimilars Newco Limited, a U.K. private limited company (“Biosimilars Newco” and, collectively with Biocon UK, the “Confessing Parties”), and Biocon Biologics Limited, a public limited company incorporated under the Indian Companies Act, 2013 (“Biocon”). Each of the parties hereto is referred to individually as a “Party” and collectively as the “Parties.”
RETIREMENT AND OPERATING CONSULTING AGREEMENT AND RELEASERetirement and Operating Consulting Agreement and Release • February 28th, 2024 • Viatris Inc • Pharmaceutical preparations • Pennsylvania
This Retirement and Consulting Agreement and Release (“Agreement”) is made by and between Rajiv Malik (“Executive”) and Viatris Inc. (together with its affiliates, the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
